Your browser doesn't support javascript.
loading
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
Cunningham, Evan B; Hajarizadeh, Behzad; Dalgard, Olav; Amin, Janaki; Hellard, Margaret; Foster, Graham R; Bruggmann, Philip; Conway, Brian; Backmund, Markus; Robaeys, Geert; Swan, Tracy; Marks, Philippa S; Quiene, Sophie; Applegate, Tanya L; Weltman, Martin; Shaw, David; Dunlop, Adrian; Bruneau, Julie; Midgard, Håvard; Bourgeois, Stefan; Thurnheer, Maria Christine; Dore, Gregory J; Grebely, Jason.
Afiliação
  • Cunningham EB; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia. ecunningham@Kirby.Unsw.Edu.Au.
  • Hajarizadeh B; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Dalgard O; Akershus University Hospital, Oslo, Norway.
  • Amin J; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Hellard M; Burnet Institute, Melbourne, VIC, Australia.
  • Foster GR; The Liver Unit, Queen Mary University of London, London, UK.
  • Bruggmann P; Arud Centres for Addiction Medicine, Zurich, Switzerland.
  • Conway B; Vancouver Infectious Diseases Center, Vancouver, BC, Canada.
  • Backmund M; Ludwig Maximilians-University Munich, Munich, Germany.
  • Robaeys G; Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Belgium.
  • Swan T; Department of Hepatology, UZ Leuven, Leuven, Belgium.
  • Marks PS; UHasselt, Hasselt, Belgium.
  • Quiene S; Treatment Action Group, New York, NY, USA.
  • Applegate TL; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Weltman M; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Shaw D; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Dunlop A; Nepean Hospital, Sydney, NSW, Australia.
  • Bruneau J; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Midgard H; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
  • Bourgeois S; Research Center, Centre Hospitalier de l'Universite de Montreal (CRCHUM), Montreal, Quebec, Canada.
  • Thurnheer MC; Akershus University Hospital, Oslo, Norway.
  • Dore GJ; Stuivenberg ZNA, Antwerp, Belgium.
  • Grebely J; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
BMC Infect Dis ; 17(1): 420, 2017 06 13.
Article em En | MEDLINE | ID: mdl-28610605

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Cooperação do Paciente / Interferon-alfa / Hepatite C / Hepacivirus Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Cooperação do Paciente / Interferon-alfa / Hepatite C / Hepacivirus Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália